MDL 020
Alternative Names: MDL-020Latest Information Update: 20 Jan 2023
At a glance
- Originator Model Medicines
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
- Available For Licensing Yes
Highest Development Phases
- Preclinical Gastrointestinal motility disorders
Most Recent Events
- 13 Jan 2023 Model Medicines has patents pending for MDL 020 (Model Medicines website, January 2023)
- 09 Jan 2023 MDL 020 is available for licensing as of 09 Jan 2023. https://www.modelmedicines.com/approach
- 09 Jan 2023 Preclinical trials in Gastrointestinal motility disorders in USA (unspecified route) (Model Medicines website, January 2023)